Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 4 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 406Neoplasms 367Prostatic Neoplasms 194Lung Neoplasms 185Colorectal Neoplasms 136Motor Activity 84Pancreatic Neoplasms 77Uterine Cervical Neoplasms 74Carcinoma, Non-Small-Cell Lung 72Head and Neck Neoplasms 67Brain Neoplasms 67Ovarian Neoplasms 59Carcinoma, Hepatocellular 50Neoplasm Metastasis 48Rectal Neoplasms 46Colonic Neoplasms 45Anxiety Disorders 45Precursor Cell Lymphoblastic Leukemia-Lymphoma 43Hematologic Neoplasms 39Depression 38Melanoma 36Glioblastoma 35Glioma 34Disease 34Multiple Myeloma 33Sarcoma 32Gastrointestinal Neoplasms 32Urinary Bladder Neoplasms 31Stomach Neoplasms 31Pain 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Cardiotoxicity × 90 days × Clear all
NCT07528586 2026-04-14

CMR-Onko

Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)

Phase NA Recruiting
93 enrolled

Cardiotoxicity

NCT06778122 2026-03-27

BREATHS

University College, London

Phase NA Recruiting
10 enrolled

Inflammation, Cardiotoxicity

NCT07442578 2026-03-18

PULSE

Dana-Farber Cancer Institute

Phase NA Active not recruiting
20 enrolled

Cardiovascular Diseases, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡